Alta-innovations news

NewsRSS FeedAtom Feed

Mercia Takeover

Date:
22/03/2016

PsiOxus Therapeutics announces positive data in cancer-related cachexia clinical trial".

Description
Mid-Stage Clinical Study of wasting disease therapeutic MT-102 shows reversal of cancer related wasting.
Date:
13/11/2013

Alta Innovations completes new licence with Cytox

Description
Alta Innovations is pleased to announce it has entered into a new licence agreement with Cytox Limited, a University of Birmingham spinout company developing laboratory services for the in-vitro assessment of risk of dementias such as Alzheimer's disease.
Date:
26/09/2013
Displaying 11 to 20 of 44